NEW YORK, May 13, 2022--PAVmed and Lucid Diagnostics Chairman & CEO Lishan Aklog, M.D. named Top 50 Healthcare Technology CEO.
NEW YORK, May 11, 2022--Lucid Diagnostics provides business update and preliminary first quarter 2022 financial results.
NEW YORK, May 09, 2022--Lucid’s first commercial payer agreement provides in-network access and payment for its EsoGuard® DNA test to over 8 million covered lives.